Sanofi SA (SAN) PT Set at €75.00 by Sanford C. Bernstein
Sanofi SA (EPA:SAN) has been given a €75.00 ($82.42) price objective by equities researchers at Sanford C. Bernstein in a note issued to investors on Wednesday. The brokerage currently has a a “neutral” rating on the stock.
SAN has been the subject of several other research reports. JPMorgan Chase & Co. reissued a “sell” rating on shares of Sanofi SA in a research report on Tuesday, October 4th. BNP Paribas set a €78.00 ($85.71) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Wednesday, September 14th. Jefferies Group set a €74.00 ($81.32) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Thursday, October 13th. Deutsche Bank AG set a €95.00 ($104.40) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, October 13th. Finally, Independent Research GmbH set a €77.00 ($84.62) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Thursday, June 30th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of €85.24 ($93.67).
Sanofi SA (EPA:SAN) traded down 0.35% during trading on Wednesday, reaching €68.62. 747,374 shares of the company traded hands. The company’s 50-day moving average price is €25.91 and its 200 day moving average price is €25.76. Sanofi SA has a 52 week low of €22.81 and a 52 week high of €68.79. The firm has a market capitalization of €88.31 billion and a price-to-earnings ratio of 21.34.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/sanofi-sa-san-pt-set-at-75-00-by-sanford-c-bernstein.html
Sanofi SA Company Profile
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.